A recent discovery ( highlights the importance of studying rare APOE variants in Alzheimer’s disease. Watch how we use our Smart Genome platform to query for the presence of this rare protective variant, c.460C>A (p.Arg154Ser).

Simplify Genomics has been interpreting whole genomes for over 10 years, initially operating within @humanlongevity and now independent. Consider our milestones when selecting your whole genome partner for hereditary risk, pharmacogenomics, polygenic risk, and wellness traits.

On Adverse Drug Events Awareness Day, Simplify Genomics supports the efforts to incorporate pharmacogenomic testing into standard patient care. #fourthcause @AmSocietyPharm

Approximately 25% of US adults take statins for lipid management. We find that ~30% of patients surveyed have non-normal function for SLCO1B1, which can predispose patients to an increased risk of myopathy. Knowing your patient’s SLCO1B1 function can help you manage side effects.

Simplify Genomics supports #MedicalGeneticsAwareness Week and joins @TheACMG in celebrating all the critical contributions from medical genomics healthcare professionals around the world to improve #patientcare.

RT @GenomeWeb: Simplify Genomics Eyes Preventative Testing Market with Automated Genome Reporting Platform. A spinoff of personalized healt….

On Rare Disease Day, let Simplify Genomics be your genome interpretation partner and empower your patient care with our clinical reporting and Smart GenomeTM platform. #RareDiseaseDay #RareDiseaseDay2024

Simplify Genomics receives accreditation from the College of American Pathologists @Pathologists .

RT @GENbio: Human Longevity Spin-Out Aims to Tap into Variant Interpretation Market. Simplify Genomics recently emerged from development mo….